{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:44:35Z","timestamp":1789771475287,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["2021\/ATRG2028"],"award-info":[{"award-number":["2021\/ATRG2028"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Public Health"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.puhe.2026.106384","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:06:47Z","timestamp":1783087607000},"page":"106384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impacts of hepatitis B and C prevention programmes on long-term outcomes of advanced liver disease and hepatocellular carcinoma: A systematic review"],"prefix":"10.1016","volume":"258","author":[{"given":"Shenghan","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8227-1127","authenticated-orcid":false,"given":"Putu Novi Arfirsta","family":"Dharmayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Lewandowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Wijekulasuriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1055-3666","authenticated-orcid":false,"given":"Gifty","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2525-9241","authenticated-orcid":false,"given":"Ann","family":"Carrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Vizheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9025-2057","authenticated-orcid":false,"given":"Rose","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Goodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8421-5476","authenticated-orcid":false,"given":"Jacob","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"Zekry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7744-8717","authenticated-orcid":false,"given":"Yvonne","family":"Zurynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.puhe.2026.106384_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3350\/cmh.2022.0316","article-title":"Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: a DALY-based analysis of the global burden of disease 2019 study","volume":"29","author":"Choi","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib3","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1111\/liv.14647","article-title":"Health related quality of life in chronic liver diseases","volume":"40","author":"Cortesi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.puhe.2026.106384_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102252","article-title":"Survival of primary liver cancer for people from culturally and linguistically diverse backgrounds in Australia","volume":"81","author":"Nguyen","year":"2022","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.puhe.2026.106384_bib5","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.cgh.2021.07.024","article-title":"A conceptual model for implementation and evaluation of interventions across the hepatocellular carcinoma care continuum","volume":"20","author":"Montealegre","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib6","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S1473-3099(16)30208-0","article-title":"Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses","volume":"16","author":"Zhou","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.puhe.2026.106384_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2015.04.026","article-title":"Immigration and viral hepatitis","volume":"63","author":"Sharma","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/1753-6405.12826","article-title":"Cultural and linguistic diversity of people living with chronic hepatitis B in 2011-2016: changing migration, shifting epidemiology","volume":"42","author":"MacLachlan","year":"2018","journal-title":"Aust N Z J Publ Health"},{"key":"10.1016\/j.puhe.2026.106384_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3961\/jpmph.21.151","article-title":"Trends of the global hepatitis C disease burden: strategies to achieve elimination","volume":"54","author":"Brunner","year":"2021","journal-title":"J Prev Med Publ Health"},{"key":"10.1016\/j.puhe.2026.106384_bib12","article-title":"Hepatocellular carcinoma amongst Aboriginal and Torres Strait Islander peoples of Australia","volume":"36","author":"Wigg","year":"2021","journal-title":"Clin Med"},{"key":"10.1016\/j.puhe.2026.106384_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.2208","article-title":"Liver cancer etiology in Asian subgroups and American Indian, Black, Latino, and white populations","volume":"8","author":"Pinheiro","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.puhe.2026.106384_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL clinical practice guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib15","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL clinical practice guidelines: management of hepatitis C virus infection","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.puhe.2026.106384_bib17","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12072-016-9736-3","article-title":"APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing","volume":"10","author":"Omata","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.puhe.2026.106384_bib18","series-title":"Clinical Testing and Diagnosis for Hepatitis B","year":"2025"},{"key":"10.1016\/j.puhe.2026.106384_bib19","series-title":"Clinical Screening and Diagnosis for Hepatitis C","year":"2025"},{"key":"10.1016\/j.puhe.2026.106384_bib20","series-title":"Fifth National Hepatitis C Strategy 2018\u20132022","year":"2022"},{"key":"10.1016\/j.puhe.2026.106384_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10900-019-00699-6","article-title":"Effectiveness of interventions for hepatitis B and C: a systematic review of vaccination, screening, health promotion and linkage to care within higher income countries","volume":"45","author":"Ortiz","year":"2020","journal-title":"J Community Health"},{"key":"10.1016\/j.puhe.2026.106384_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.14324","article-title":"Global timing of hepatitis C virus elimination in high-income countries","volume":"40","author":"Razavi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.puhe.2026.106384_bib23","series-title":"JBI Manual for Evidence Synthesis","article-title":"Mixed methods systematic reviews","author":"Lizarondo","year":"2024"},{"key":"10.1016\/j.puhe.2026.106384_bib25","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Chandler","year":"2019"},{"key":"10.1016\/j.puhe.2026.106384_bib26","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"Br Med J"},{"key":"10.1016\/j.puhe.2026.106384_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jvh.13233","article-title":"Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: the LiveRLife study","volume":"27","author":"Bajis","year":"2020","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.puhe.2026.106384_bib28","doi-asserted-by":"crossref","first-page":"v39","DOI":"10.1093\/jac\/dkz455","article-title":"HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study","volume":"74","author":"Barror","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.puhe.2026.106384_bib29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jiph.2022.11.021","article-title":"Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: pathways to regain progress","volume":"16","author":"Blach","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.puhe.2026.106384_bib30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2018.04.013","article-title":"Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C","volume":"69","author":"Bloom","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jhep.2016.10.028","article-title":"Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada","volume":"66","author":"Janjua","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib32","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1111\/jgh.15473","article-title":"Community screening identifies undiagnosed chronic liver disease in high-risk populations","volume":"36","author":"Maher","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.20963","article-title":"Screening for hepatocellular carcinoma and survival in patients with cirrhosis after hepatitis C virus cure","volume":"7","author":"Mezzacappa","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.puhe.2026.106384_bib34","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jvh.13989","article-title":"Epidemiology, treatment patterns and survival in Canadian patients with chronic hepatitis B-related hepatocellular carcinoma","volume":"31","author":"Sachar","year":"2024","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.puhe.2026.106384_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.puhe.2025.105894","article-title":"A shared care program for the management of patients with chronic hepatitis B in a Canadian primary care refugee clinic","volume":"247","author":"Talavlikar","year":"2025","journal-title":"Public Health"},{"key":"10.1016\/j.puhe.2026.106384_bib36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/HEP.0000000000000779","article-title":"Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries","volume":"80","author":"Tian","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.puhe.2026.106384_bib37","article-title":"Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia","volume":"51","author":"Tillakeratne","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.puhe.2026.106384_bib38","article-title":"Implementation of universal hepatitis C virus screening in a tertiary cancer center","volume":"22","author":"Torres","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.puhe.2026.106384_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamainternmed.2015.6011","article-title":"Cost-effectiveness of early treatment of hepatitis C virus genotype 1 by stage of liver fibrosis in a US treatment-naive population","volume":"176","author":"Chahal","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.puhe.2026.106384_bib40","doi-asserted-by":"crossref","first-page":"ofy353","DOI":"10.1093\/ofid\/ofy353","article-title":"Cost-effectiveness of hepatitis B virus infection screening and treatment or vaccination in 6 high-risk populations in the United States","volume":"6","author":"Chahal","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.puhe.2026.106384_bib41","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jval.2016.01.010","article-title":"Economic and public health impacts of policies restricting access to hepatitis C treatment for medicaid patients","volume":"19","author":"Chidi","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.puhe.2026.106384_bib42","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1186\/s12913-024-11793-4","article-title":"Cost-effectiveness analysis of emergency department-based hepatitis C screening and linkage-to-care program","volume":"24","author":"Choi","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.puhe.2026.106384_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.amepre.2022.08.016","article-title":"Economic impact of universal hepatitis C virus testing for middle-aged adults who inject drugs","volume":"64","author":"Jiang","year":"2023","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.puhe.2026.106384_bib44","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10198-023-01652-0","article-title":"Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis","volume":"25","author":"Marcellusi","year":"2024","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.puhe.2026.106384_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/AOG.0000000000004652","article-title":"Universal hepatitis B antibody screening and vaccination in pregnancy: a cost-effectiveness analysis","volume":"139","author":"Prabhu","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.puhe.2026.106384_bib46","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1080\/14767058.2021.1949442","article-title":"A cost-effectiveness analysis of universal hepatitis C screening in all United States pregnancies","volume":"35","author":"Susich","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.puhe.2026.106384_bib47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/cid\/ciab405","article-title":"Cost-effectiveness of 1-time universal screening for chronic hepatitis B infection in adults in the United States","volume":"74","author":"Toy","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.puhe.2026.106384_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0313898","article-title":"Cost-effectiveness of monitoring and liver cancer surveillance among patients with inactive chronic hepatitis B","volume":"20","author":"Toy","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.puhe.2026.106384_bib49","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/liv.13519","article-title":"In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered","volume":"38","author":"Younossi","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.puhe.2026.106384_bib50","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4161\/hv.23827","article-title":"Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy: an a posteriori evaluation and forecast of future benefits","volume":"9","author":"Boccalini","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.puhe.2026.106384_bib51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/infdis\/jiab401","article-title":"Universal infant hepatitis B virus (HBV) vaccination for 35 years: moving toward the eradication of HBV","volume":"225","author":"Chang","year":"2022","journal-title":"JID (J Infect Dis)"},{"issue":"3","key":"10.1016\/j.puhe.2026.106384_bib52","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/j.gastro.2025.10.295","article-title":"Hepatitis B vaccination: a remarkable success story that must continue","volume":"170","author":"Lok","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1016\/j.puhe.2026.106384_bib53","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jceh.2012.09.001","article-title":"Chronic hepatitis B virus infection and pregnancy","volume":"2","author":"Kumar","year":"2012","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib54","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/ACM.0b013e31802d8f68","article-title":"Academic health center management of chronic diseases through knowledge networks: project ECHO","volume":"82","author":"Arora","year":"2007","journal-title":"Acad Med"},{"key":"10.1016\/j.puhe.2026.106384_bib55","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","article-title":"Outcomes of treatment for hepatitis C virus infection by primary care providers","volume":"364","author":"Arora","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.puhe.2026.106384_bib56","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1186\/s12879-017-2775-0","article-title":"The future of viral hepatitis testing: innovations in testing technologies and approaches","volume":"17","author":"Peeling","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.puhe.2026.106384_bib57","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.drugpo.2015.07.002","article-title":"Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: the LiveRLife study","volume":"26","author":"Marshall","year":"2015","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.puhe.2026.106384_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.103982","article-title":"Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: the TEMPO pilot study","volume":"114","author":"Grebely","year":"2023","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.puhe.2026.106384_bib59","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1186\/s12889-019-7604-5","article-title":"Outcomes of a tertiary-based innovative approach to engage primary care providers in provision of hepatitis C treatment in community settings","volume":"19","author":"Pourmarzi","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.puhe.2026.106384_bib60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12029-022-00851-x","article-title":"Patient-, provider-, and system-level barriers to surveillance for hepatocellular carcinoma in high-risk patients in the USA: a scoping review","volume":"54","author":"Beal","year":"2023","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.puhe.2026.106384_bib61","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/jvh.12910","article-title":"Aiming for elimination: outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C","volume":"25","author":"Wade","year":"2018","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.puhe.2026.106384_bib62","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.cgh.2013.04.024","article-title":"Education provides significant benefits to patients with hepatitis B virus or hepatitis C virus infection: a systematic review","volume":"11","author":"Shah","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.puhe.2026.106384_bib63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.31128\/AJGP-02-20-5225","article-title":"Facilitating hepatitis B clinical management in general practice: a qualitative investigation","volume":"49","author":"Wallace","year":"2020","journal-title":"Aust J Gen Pract"}],"container-title":["Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350626002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033350626002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:06:56Z","timestamp":1789186016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033350626002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"alternative-id":["S0033350626002532"],"URL":"https:\/\/doi.org\/10.1016\/j.puhe.2026.106384","relation":{},"ISSN":["0033-3506"],"issn-type":[{"value":"0033-3506","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacts of hepatitis B and C prevention programmes on long-term outcomes of advanced liver disease and hepatocellular carcinoma: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.puhe.2026.106384","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health.","name":"copyright","label":"Copyright"}],"article-number":"106384"}}